One Biosciences, a Paris, France-based techbio and single-cell precision oncology startup, received €3.3m in non-dilutive public funding. The grant was awarded by Bpifrance under the i-Démo 5 project call, an integral part of the government’s France 2030 nationwide industrial and innovation investment initiative....See more